Skip to main content
SpringerLink
Log in

Calciumantagonisten bei organischen und funktionellen peripheren Durchblutungsstörungen

  • Chapter
Calciumantagonisten

  • 26 Accesses

Zusammenfassung

Im Folgenden werden Epidemiologie, Klinik, Diagnose und Pathophysiologie der PAVK, Thrombangiitis obliterans, Akrozyanose, des RaynaudPhänomens, Ergotismus, Blue-toe-Phänomens, von Frostbeulen und Erfrierungen ausführlich im Hinblick auf eine Therapie der jeweiligen Erkrankung mit Calciumantagonisten beschrieben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aldoori, M, Campbell, WB, Dieppe, PA (1986) Nifedipine in the treatment of Raynaud’s Syndrome. Cardiovascular Research 20 (6): 466-470

    Article  PubMed  CAS  Google Scholar 

  2. Allen, EV, Brown, GE (1932) Raynaud’s disease: a critical review of minimal requisites for diagnosis. American Journal of Medical Sciences 183: 183-187

    Article  Google Scholar 

  3. Alpert MA, Pressly TA, Mukerji, V, Lampbert, CR, Mukerji, B, Panayiotou, H, Sharp GC (1991) Acute and long term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. American Journal of Cardiology 68 (17): 1687-1691

    Article  PubMed  CAS  Google Scholar 

  4. Amabile, G, Serradimigni, A (1987) Study of nicardipine in moderate hypertension and its influence on lipid metabolism. Pract Med 26: 41-42

    Google Scholar 

  5. Andersen, LB, Thestrup-Pedersen, K, Sell, A (1988) Nifedipine treatment of Raynaud’s phenomenon secondary to chemotherapy. Dermatologica 177 (1): 19-20

    Article  PubMed  CAS  Google Scholar 

  6. Antti-Poika I, Pohjolainen T, Alaranta H (1990) Severe frostbite of the upper extremities — a psychosocial problem mostly associated with alcohol abuse [see comments] Scand-J-SocMed. 18 (1): 59-61

    CAS  Google Scholar 

  7. Anttonen H (1993) Occupational needs and evaluation methods for cold protective clothing. Arctic-Med-Res. 52 (Suppl 9): 1-76

    PubMed  Google Scholar 

  8. Arbeitsgruppe Sklerodermie (1986) Klinik der progressiven systemischen Sklerodermie. Hautarzt 37: 320

    Google Scholar 

  9. Bernardi D, Bartoli P, Ferreri A, Geri AB, Leri A (1988) Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound. Angiology 39 (11): 942-952

    Article  PubMed  CAS  Google Scholar 

  10. Beeley JM, Smith DJ, Oakley EH (1993) Environmental hazards and health. Br-MedBull 49 (2): 305-325

    CAS  Google Scholar 

  11. Belcaro G, Nicholaides AN (1989) Microvascular evaluation of the effect of nifedipine in vascular patients by laser-Doppler flowmetry. Angiology 40 (8): 689-694

    Article  PubMed  CAS  Google Scholar 

  12. Beykirch H, Reuter W, Voigt H, Herrmann W (1989) Lipidstoffwechsel and periphere Hämodynamik bei Arteriosclerosis obliterans unter Nifedipin. Zeitschrift für die gesamte Innere Medizin and ihre Grenzgebiete, 44 (3): 77-79

    CAS  Google Scholar 

  13. Brotzu G, Falchi S, Mannu B, Montisci R, Petruzzo P, Staico R (1989) The importance of presynaptic beta receptors in Raynaud’s disease. Journal of vascular surgery 9 (6): 767-771

    PubMed  CAS  Google Scholar 

  14. Bursztyn M, Grossman E, Rosenthal T (1985) Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. American Heart Journal 110 (1): 96-101

    Article  PubMed  CAS  Google Scholar 

  15. Chacon-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Munoz I, Concha M (1994) Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs. Angiology 45 (7): 647-653

    Article  PubMed  CAS  Google Scholar 

  16. Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS (1989) Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud’s phenomenon. Angiology 40 (2): 122-128

    Article  PubMed  CAS  Google Scholar 

  17. Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon (1991). French Cooperative Multicenter Group for Raynaud phenomenon, Paris, Franc. American Heart Journal 122 (2): 352-355

    Google Scholar 

  18. Crouch C, Smith WL (1990) Long term sequelae of frostbite. Pediatr-Radiol. 20 (5): 365-366

    Article  PubMed  CAS  Google Scholar 

  19. Diehm C, Müller-Bühl U, Mechtersheimer U, Mörl H (1984) Lokale Isosorbitdinitrat-Salbenbehandlung beim Rauynaud-Phänomen. Vasa 13: 72-74

    PubMed  CAS  Google Scholar 

  20. Diehm C, Müller-Bühl U (eds) (1991) Angiologie — Praxis der Gefäßkrankheiten, W. Kohlhammer, Stuttgart, Berlin, Köln

    Google Scholar 

  21. Diehm C, Weiss T (eds) (1995) Die periphere arterielle Verschlußkrankheit, Lingua Med, Neu Isenburg

    Google Scholar 

  22. Diehm C, Schäfer M (eds) (1993) Das Buerger-Syndrom — Thrombangiitis obliterans. Springer, Berlin, Heidelberg

    Google Scholar 

  23. Fisher M, Grotta J (1993) New uses for calcium channel blockers. Therapeutic implications. Drugs 46 (6): 961-975

    Article  PubMed  CAS  Google Scholar 

  24. Frey M, Just H (1994) Role of calcium antagonists in progression of arteriosclerosis: Evidence from animal experiments and clinical experience. Part I. Preventive effects of calcium antagonists in animal experiments. Basic res cardiol suppl 89 (1): 161-176

    CAS  Google Scholar 

  25. Goette DK (1990 Aug) Chilblains (perniosis). J-Am-Acad-Dermatol. 23 (1): 257-262

    Article  PubMed  CAS  Google Scholar 

  26. Greer IA (1987) Therapeutic progress-review XXVIII. Platelet function and calcium channel blocking agents. Journal of Clinical Pharmacology and Therapeutics 12 (4): 213-222

    Article  CAS  Google Scholar 

  27. Grodzinska L, Basista M, Basista E, Slawinski M, Swies J, Stachura J, Ohlrogge R (1987) Nitrendipine stimulated release of prostacyclin-like substance in normal and atherosclerotic animals. Arzneimittel Forschung 37 (4): 412-415

    PubMed  CAS  Google Scholar 

  28. Groechenig E (1994 Oct 22) Treatment of frostbite with iloprost [letter] Lancet. 344 (8930): 1152-1153

    CAS  Google Scholar 

  29. Grün G, Byon KY, Tritthart HA, Fleckenstein A (1970) Inhibition of automaticity and contractility of isolated human uterine muscle by Ca-antagonistic compounds. Pfliigers Arch Eur J Physiol 319; 118

    Google Scholar 

  30. Harvey CK (1992) An overview of cold injuries. J Am Podiatr Med Assoc. 82 (8): 436-438

    PubMed  CAS  Google Scholar 

  31. Helzer-Julin M (1994) Sun, heat, and cold injuries in cyclists. Clin-Sports-Med 13 (1): 219-234

    PubMed  CAS  Google Scholar 

  32. Hiramatsu K, Yamagishi F, Kubota T, Yamada T (1982) Acute effect of the calcium antagonist nifedipine on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J 104: 1346-1350

    Article  PubMed  CAS  Google Scholar 

  33. Kannel WB, Skinner JR, Schwartz MJ, Shurtleff D (1970) Intermittent claudication: Incidence in the Framingham Study. Circulation 41: 875-883

    PubMed  CAS  Google Scholar 

  34. Kimose HH, Bagger JP, Aagard MT, Paulsen PK (1990) Placebo-controlled, double-blind study of the effect of verapamil in intermittent claudication. Angiology 41 (8): 895-898

    Google Scholar 

  35. Lacoste L et al. (1994) Oral verapamil inhibits platelet Thrombus formation in Humans. Circulation 89: 630-634

    Google Scholar 

  36. Lewis P, Psaila JV, Davies WT, Morgan RH, Woodcock JP (1989) Nifedipine in patients with peripheral vascular disease. European Journal of Vascular Surgery 3 (2): 159-164

    Article  PubMed  CAS  Google Scholar 

  37. Malinow MR (1981) Regression of atherosclerosis in humans: Fact or myth Circulation 64: 1-3

    PubMed  CAS  Google Scholar 

  38. Marshall M (1988) Moderne Therapie der arteriellen Verschlußkrankheit. Perfusion 1: 920

    Google Scholar 

  39. McCauley RL, Heggers JP, Robson MC (1990) Frostbite. Methods to minimize tissue loss. Postgrad-Med. 88 (8): 67-68, 73-77

    Google Scholar 

  40. Mills WJ Jr, O’Malley J, Kappes B (1993) Cold and freezing: a historical chronology of laboratory investigation and clinical experience. Alaska-Med. 35 (1): 89-116

    PubMed  Google Scholar 

  41. Nobbe F (1980) Erkrankungen durch Kälte oder Hitze. In: Rebentisch, E (Hrsg.) Wehrmedizin. Urban and Schwarzenberg, München, Baltimore, pp. 39.

    Google Scholar 

  42. Pola P, Savi L (1978) Peripheral vascular dynamics studied by calcium ion inhibition. Angiology 29 (7): 506-519

    Article  PubMed  CAS  Google Scholar 

  43. Revuz J (1992) Cutaneous pathology induced by cold Ann-Dermatol-Venereol. 119 (67): 455-456, 1992

    CAS  Google Scholar 

  44. Rosen L, Eltvik L, Arvesen A, Stranden E (1991) Local cold injuries sustained during military service in the Norwegian Army. Arctic-Med-Res. 50 (4): 159-165

    PubMed  CAS  Google Scholar 

  45. Russel JD, Churchill DN (1989) Calcium antagonists and acute renal failure. American Journal of Medicine 87 (3): 306-315

    Article  Google Scholar 

  46. Saito S, Shimada H (1994) Effect of prostaglandin El analogue administration on peripheral skin temperature at high altitude. Angiology. 45 (6): 455-460

    Article  PubMed  CAS  Google Scholar 

  47. Schmidt JF, Valentin N, Nielsen SL (1989) The clinical effect of felodipine and nifedipine in Raynaud’s phenomenon. European Journal of Clinical Pharmacology 37 (2): 191-192

    Article  PubMed  CAS  Google Scholar 

  48. Schmitz G, Hankowitz J, Kovacs EM (1991) Cellular processes in atherosclerosis: potential targets of Ca’ channel blockers. Atherosclerosis 88 (3): 109-132

    Article  PubMed  CAS  Google Scholar 

  49. Schrub JC, Doucet J, Gancel A, Ozenne G, Vuillermet P (1988) Insulin secretion and nicardipine: study in nine non-insulin-dependent diabetics. Sem. Hopital Paris 64 (16): 1087-1090

    Google Scholar 

  50. Skolnick AA (1992) Early data suggest clot-dissolving drug may help save frostbitten limbs from amputation [news] JAMA. 267 (15): 2008-2010, 1992

    CAS  Google Scholar 

  51. Spittell JA (1980) Vascular syndromes related to environmental temperature. In Juergens JL, Spittell JA, Fairburn NJ (eds) Peripheral Vascular Disease. Philadelphia, WB Saunders Co, pp. 585-607

    Google Scholar 

  52. Sowers JR (1992) Antiatherosclerotic effect of calcium channel blockers. Postgraduate Medicine 92 (2): 265-268

    PubMed  CAS  Google Scholar 

  53. Taylor MS (1992) Cold weather injuries during peacetime military training. Mil-Med. 157 (11): 602-604, 1992

    PubMed  CAS  Google Scholar 

  54. Thiery J, Niedmann PD, Seidel D (1987) The beneficial influence of nifedipine on the regression of the cholesterol-induced atherosclerosis in rabbits. Research in Experimental Medicine 187 (5): 359-367

    Article  PubMed  CAS  Google Scholar 

  55. Urschel JD (1990) Frostbite: predisposing factors and predictors of poor outcome. J-Trauma. 30 (3): 340-342

    Article  PubMed  CAS  Google Scholar 

  56. Virokannas H, Anttonen H (1993) Risk of frostbite in vibration-induced white finger cases. Arctic-Med-Res. 52 (2): 69-72

    PubMed  CAS  Google Scholar 

  57. Widmer LK, Stähelin HB, Nissen C, Da Silva A (1981) Venen-, Arterienkrankheiten, koronare Herzkrankheit bei Beruftätigen. Huber, Bern/Stuttgart/Wien

    Google Scholar 

Download references

Authors
  1. C. Diehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin III, Medizinische Universitätsklinik, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Wolfgang Kübler

  2. Institut für Medizinische Physik und Biophysik, Harrachgasse 21, A-8010, Graz, Österreich

    Helmut A. Tritthart

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Diehm, C., Hsu, E. (1996). Calciumantagonisten bei organischen und funktionellen peripheren Durchblutungsstörungen. In: Kübler, W., Tritthart, H.A. (eds) Calciumantagonisten. Steinkopff. https://doi.org/10.1007/978-3-642-93678-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93678-4_9

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-93679-1

  • Online ISBN: 978-3-642-93678-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation